| 英文名称 | GW6471 |
|---|---|
| 中文名称 | (S,Z)-N-(3-(4-(2-(5-甲基-2-苯基恶唑-4-基)乙氧基)苯基)-2-((4-氧代-4-(4-(三氟甲基)苯基)丁-2-烯-2-基)氨基)丙基)丙酰胺 |
| CAS号 | 880635-03-0 |
| 分子式 | C35H36F3N3O4 |
| 分子量 | 619.67 |
| MDL | MFCD07784503 |
| 英文名称 | GW6471 |
|---|---|
| 中文名称 | (S,Z)-N-(3-(4-(2-(5-甲基-2-苯基恶唑-4-基)乙氧基)苯基)-2-((4-氧代-4-(4-(三氟甲基)苯基)丁-2-烯-2-基)氨基)丙基)丙酰胺 |
| CAS号 | 880635-03-0 |
| 分子式 | C35H36F3N3O4 |
| 分子量 | 619.67 |
| MDL | MFCD07784503 |
GW6471 is a PPARα antagonist, which completely inhibits GW409544-induced activation of PPARα with an IC50 = 0.24 μM. GW6471 induces a PPARα conformation that interacts efficiently with co-repressors.GW6471 prevents apoptosis and cell cycle arrest at G0/G1 in renal cell carcinoma. It reduces enhanced fatty acid oxidation and oxidative phosphorylation associated with glycolysis inhibition.